Osteocytes and Their Messengers as Targets for the Treatment of Multiple Myeloma

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Osteocytes, the most abundant cells in the bone, orchestrate the function of osteoblasts and osteocytes to control physiological bone homeostasis. Accumulating evidence demonstrates that alteration of osteocyte function underlies the pathophysiology of several skeletal disorders, and that therapeutic targeting of factors produced by these cells improves skeletal health. Despite the advances in the knowledge of osteocyte biology, the contribution of these cells to the damaging effects of cancer in bone is practically unknown. Multiple myeloma is a plasma cell malignancy characterized by the presence of skeletal lesions and severe bone pain. Recent findings suggest that myeloma cells educate osteocytes to generate a microenvironment that is conducive to tumor progression, skeletal destruction, and bone pain. This review features some of these investigations and discusses the potential of targeting osteocytic pathways and osteocyte messengers for the treatment of multiple myeloma.

Original languageEnglish (US)
Pages (from-to)49-56
Number of pages8
JournalClinical Reviews in Bone and Mineral Metabolism
Volume15
Issue number1
DOIs
StatePublished - Mar 1 2017

Fingerprint

Osteocytes
Multiple Myeloma
Bone and Bones
Therapeutics
Pain
Bone Neoplasms
Plasma Cells
Osteoblasts
Cell Biology
Neoplasms
Homeostasis
Health

Keywords

  • Apoptosis
  • Myeloma
  • Notch signaling
  • Osteocytes
  • Rankl
  • Sclerostin

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Orthopedics and Sports Medicine
  • Endocrinology

Cite this

Osteocytes and Their Messengers as Targets for the Treatment of Multiple Myeloma. / Delgado-Calle, Jesus.

In: Clinical Reviews in Bone and Mineral Metabolism, Vol. 15, No. 1, 01.03.2017, p. 49-56.

Research output: Contribution to journalReview article

@article{d20d67e6f27443bfa175819833cd61c4,
title = "Osteocytes and Their Messengers as Targets for the Treatment of Multiple Myeloma",
abstract = "Osteocytes, the most abundant cells in the bone, orchestrate the function of osteoblasts and osteocytes to control physiological bone homeostasis. Accumulating evidence demonstrates that alteration of osteocyte function underlies the pathophysiology of several skeletal disorders, and that therapeutic targeting of factors produced by these cells improves skeletal health. Despite the advances in the knowledge of osteocyte biology, the contribution of these cells to the damaging effects of cancer in bone is practically unknown. Multiple myeloma is a plasma cell malignancy characterized by the presence of skeletal lesions and severe bone pain. Recent findings suggest that myeloma cells educate osteocytes to generate a microenvironment that is conducive to tumor progression, skeletal destruction, and bone pain. This review features some of these investigations and discusses the potential of targeting osteocytic pathways and osteocyte messengers for the treatment of multiple myeloma.",
keywords = "Apoptosis, Myeloma, Notch signaling, Osteocytes, Rankl, Sclerostin",
author = "Jesus Delgado-Calle",
year = "2017",
month = "3",
day = "1",
doi = "10.1007/s12018-017-9227-7",
language = "English (US)",
volume = "15",
pages = "49--56",
journal = "Clinical Reviews in Bone and Mineral Metabolism",
issn = "1534-8644",
publisher = "Humana Press",
number = "1",

}

TY - JOUR

T1 - Osteocytes and Their Messengers as Targets for the Treatment of Multiple Myeloma

AU - Delgado-Calle, Jesus

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Osteocytes, the most abundant cells in the bone, orchestrate the function of osteoblasts and osteocytes to control physiological bone homeostasis. Accumulating evidence demonstrates that alteration of osteocyte function underlies the pathophysiology of several skeletal disorders, and that therapeutic targeting of factors produced by these cells improves skeletal health. Despite the advances in the knowledge of osteocyte biology, the contribution of these cells to the damaging effects of cancer in bone is practically unknown. Multiple myeloma is a plasma cell malignancy characterized by the presence of skeletal lesions and severe bone pain. Recent findings suggest that myeloma cells educate osteocytes to generate a microenvironment that is conducive to tumor progression, skeletal destruction, and bone pain. This review features some of these investigations and discusses the potential of targeting osteocytic pathways and osteocyte messengers for the treatment of multiple myeloma.

AB - Osteocytes, the most abundant cells in the bone, orchestrate the function of osteoblasts and osteocytes to control physiological bone homeostasis. Accumulating evidence demonstrates that alteration of osteocyte function underlies the pathophysiology of several skeletal disorders, and that therapeutic targeting of factors produced by these cells improves skeletal health. Despite the advances in the knowledge of osteocyte biology, the contribution of these cells to the damaging effects of cancer in bone is practically unknown. Multiple myeloma is a plasma cell malignancy characterized by the presence of skeletal lesions and severe bone pain. Recent findings suggest that myeloma cells educate osteocytes to generate a microenvironment that is conducive to tumor progression, skeletal destruction, and bone pain. This review features some of these investigations and discusses the potential of targeting osteocytic pathways and osteocyte messengers for the treatment of multiple myeloma.

KW - Apoptosis

KW - Myeloma

KW - Notch signaling

KW - Osteocytes

KW - Rankl

KW - Sclerostin

UR - http://www.scopus.com/inward/record.url?scp=85011545862&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011545862&partnerID=8YFLogxK

U2 - 10.1007/s12018-017-9227-7

DO - 10.1007/s12018-017-9227-7

M3 - Review article

AN - SCOPUS:85011545862

VL - 15

SP - 49

EP - 56

JO - Clinical Reviews in Bone and Mineral Metabolism

JF - Clinical Reviews in Bone and Mineral Metabolism

SN - 1534-8644

IS - 1

ER -